
- With Mayo Clinic gastroenterologist
Michael Picco, M.D.
read biographyclose windowBiography of
Michael Picco, M.D.
Michael Picco, M.D.
Dr. Michael F. Picco has been with Mayo Clinic since 1999. He is board certified in internal medicine and gastroenterology. Dr. Picco is an assistant professor of medicine at Mayo Clinic College of Medicine and a consultant in gastroenterology at Mayo Clinic in Florida.
He has authored numerous publications in the area of gastroenterology, including original research, editorials and textbook chapters. He works with a team of gastroenterologists that takes care of complex gastrointestinal conditions and has a particular interest in diarrheal illnesses and inflammatory bowel diseases (ulcerative colitis and Crohn's disease). He is also active in medical education in training new gastroenterologist and internists.
"MayoClinic.com is an invaluable resource for patients and their families," Dr. Picco said. "Informed patients are better able to participate in their own health care. A patient's participation is vital to the treatment of his or her disease. I hope to assist in helping patients understand their digestive problems and current treatments that are offered. This will allow for better communication between patients, their physicians and other health care professionals."
Dr. Picco serves as a reviewer of new research for several medical journals in the area of gastroenterology and is an active member of the American Gastroenterological Association, American College of Gastroenterology and the Crohn's & Colitis Foundation of America. He serves on numerous committees that address physician training, research and clinical practice in gastroenterology, both at Mayo Clinic and at the national level.
"Patients need to know about their disease, what to expect, the latest treatments and side effects so that they can make informed decisions about their health care. Gastrointestinal disease affects not only patients but also their families. My goal is to assure that our Web site provides accurate, reliable information and resources for patients. We must always provide the latest, most cutting-edge information to assist patients in dealing with their medical problems," Dr. Picco said.
Complications (1)
- Hepatitis C: What happens in end-stage liver disease?
Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get StartedQuestion
Hepatitis C: How common is sexual transmission?
How common is sexual transmission of hepatitis C?
Answer
from Michael Picco, M.D.
Hepatitis C is transmitted primarily by exposure to blood containing the hepatitis C virus. Transmission rarely occurs from exposure to other infected body fluids, such as semen.
If you're in a long-term, monogamous relationship with a partner who has hepatitis C, your risk of sexual transmission is low — 0 to 0.6 percent a year. For these monogamous couples, the Centers for Disease Control and Prevention (CDC) doesn't recommend routine condom use to prevent transmission. But couples should avoid sharing razors, toothbrushes and nail clippers.
The risk of transmission is slightly higher — about 1 percent a year — if you have multiple short-term sexual relationships with partners who have hepatitis C. This risk increases if a partner is also infected with HIV. Under these circumstances, the CDC recommends routine condom use to reduce your risk of transmission.
If you're concerned about hepatitis C, talk to your doctor. Hepatitis C can be diagnosed by a blood test. Treatment may include medications to help clear the virus from the bloodstream.
Next questionHepatitis C: What happens in end-stage liver disease?
- Orlando R, et al. Hepatitis C virus infection: Sexual or non-sexual transmission between spouses? A case report and review of the literature. Infection. 2007;35:465.
- Screening for hepatitis C virus infection. U.S. Preventive Services Task Force. http://www.ahrq.gov/downloads/pub/prevent/pdfser/hepcser.pdf. Accessed Sept. 18, 2009.
- Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology. 2002;36(suppl):S99.
- Alter MJ, et al. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recommendations and Reports. 1998;47:1. http://www.cdc.gov/mmwr/preview/mmwrhtml/00055154.htm. Accessed Sept. 18, 2009.
- Ghany MG, et al. AASLD practice guidelines: Diagnosis, management and treatment hepatitis C: An update. Hepatology. 2009;49:1335.